慢性粒细胞白血病的进展 - Suppr

Suppr

超能文献

Advances in CML.

作者信息

Goldman John M

机构信息

Hematology Branch, Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA.

出版信息

Clin Adv Hematol Oncol. 2007 Apr;5(4):270-2, 292.

PMID:17607286

Abstract

摘要

相似文献

Advances in CML.慢性粒细胞白血病的进展

Clin Adv Hematol Oncol. 2007 Apr;5(4):270-2, 292.

Chronic myeloid leukemia: a historical perspective.慢性髓细胞白血病：历史透视。

Semin Hematol. 2010 Oct;47(4):302-11. doi: 10.1053/j.seminhematol.2010.07.001.

Concomitant t(3;3)(q21;q26), trisomy 19, and E255V mutation associated with imatinib mesylate resistance in chronic myelogenous leukemia.伴有t(3;3)(q21;q26)、19号染色体三体以及E255V突变，与慢性粒细胞白血病对甲磺酸伊马替尼耐药相关。

Cancer Genet Cytogenet. 2009 Apr 1;190(1):46-8. doi: 10.1016/j.cancergencyto.2008.11.012.

Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy.对STI-571癌症治疗耐药的费城染色体阳性白血病患者中BCR-ABL基因突变的检测

Leuk Res. 2008 Nov;32(11):1724-34. doi: 10.1016/j.leukres.2008.04.023. Epub 2008 Jul 7.

Professor John M. Goldman, CML pioneer 1938-2013.约翰·M·戈德曼教授，慢性粒细胞白血病研究先驱，1938 - 2013年。

Int J Hematol. 2014 Feb;99(2):103-4. doi: 10.1007/s12185-014-1499-9.

[Circumventing resistance to imatinib therapy in chronic myeloid leukemia].[克服慢性髓性白血病对伊马替尼治疗的耐药性]

Gan To Kagaku Ryoho. 2009 Apr;36(4):544-7.

Monitoring of minimal residual disease using WT1 assay for patients with chronic myeloid leukemia who undergo allogeneic stem cell transplantation.对接受异基因干细胞移植的慢性髓性白血病患者使用WT1检测法监测微小残留病。

Bone Marrow Transplant. 2004 Oct;34(7):653-4. doi: 10.1038/sj.bmt.1704620.

Flying under the radar: the new wave of BCR-ABL inhibitors.低调发展：BCR-ABL抑制剂的新潮流

Nat Rev Drug Discov. 2007 Oct;6(10):834-48. doi: 10.1038/nrd2324.

Blastic phase of chronic myelogenous leukemia.慢性粒细胞白血病的急变期

Clin Adv Hematol Oncol. 2005 Jul;3(7):547-52.

Imatinib mesylate resistance in a chronic myeloid leukemia patient with a novel e8a2 BCR-ABL transcript variant.一名慢性髓性白血病患者携带新型e8a2 BCR-ABL转录本变体，对甲磺酸伊马替尼耐药。

Acta Haematol. 2008;120(3):146-9. doi: 10.1159/000178145. Epub 2008 Nov 28.

引用本文的文献

Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.在 AML 和 CML 中，CD34+/CD38- 和 CD34+/CD38+ 干细胞和祖细胞中的靶表达谱的描绘。

Blood Adv. 2020 Oct 27;4(20):5118-5132. doi: 10.1182/bloodadvances.2020001742.

Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML.基于免疫疗法的 AML 和 CML 中白血病干细胞的靶向和清除。

Int J Mol Sci. 2019 Aug 29;20(17):4233. doi: 10.3390/ijms20174233.

Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques.流式细胞术免疫微珠分析法检测慢性髓性白血病中的BCR-ABL1融合蛋白：与荧光原位杂交和聚合酶链反应技术的比较

PLoS One. 2015 Jun 25;10(6):e0130360. doi: 10.1371/journal.pone.0130360. eCollection 2015.

Why doesn't imatinib cure chronic myeloid leukemia?伊马替尼为什么不能治愈慢性髓性白血病？

Oncologist. 2010;15(2):182-6. doi: 10.1634/theoncologist.2009-0297. Epub 2010 Feb 2.

An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia.一种准确快速的流式细胞术诊断 BCR-ABL 阳性急性淋巴细胞白血病。

Haematologica. 2009 Dec;94(12):1767-70. doi: 10.3324/haematol.2009.010900. Epub 2009 Jul 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验